Mercer Global Advisors
RCKT icon

Mercer Global Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Mercer Global Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
108,028
+25,480
+31% +$84.7K ﹤0.01% 2592
2026
Q1 		$296K Buy
82,548
+66,502
+414% +$264K ﹤0.01% 2450
2025
Q4 		$56.3K Buy
16,046
+601
+4% +$2.06K ﹤0.01% 2780
2025
Q3 		$50.4K Buy
+15,445
New +$48.6K ﹤0.01% 2587

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mercer Global Advisors's RCKT Position: Q2 2026 in Review

Mercer Global Advisors increased its Rocket Pharmaceuticals (RCKT) stake by 31% in Q2 2026, buying an estimated $84.7K and bringing the position to 108,028 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Mercer Global Advisors first reported a position in RCKT in Q3 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Mercer Global Advisors held 108,028 shares of Rocket Pharmaceuticals worth $369K as of Q2 2026.
  • Mercer Global Advisors bought 25,480 Rocket Pharmaceuticals shares in Q2 2026, an estimated $84.7K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2592 holding.
  • Mercer Global Advisors first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.